A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling

• Published in: Revista Brasileira de ginecologia e obstetrícia Vol. 45; no. 5; pp. 235 - 241
• Main Authors: Lichtenfels, Martina, Lorenzi, Noely Paula Cristina, Tacla, Maricy, Yokochi, Kaori, Frustockl, Flávia, Silva, Camila Alves, Silva, André Luiz da, Termini, Lara, Farias, Caroline Brunetto
• Format: Journal Article
• Language: English
• Published: Brazil Thieme Revinter Publicações Ltda 01-05-2023; Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
• Subjects: Brazil; cytology; diagnostic screening programs; early detection of cancer; Early Detection of Cancer - methods; Female; human papillomavirus; Humans; Mass Screening; OBSTETRICS & GYNECOLOGY; Original; Papillomaviridae; Papillomavirus Infections - diagnosis; Patient Acceptance of Health Care; Self Care; uterine cervical neoplasms; Uterine Cervical Neoplasms - diagnosis; Uterine Cervical Neoplasms - prevention & control; Vaginal Smears; Brazil; Detecção precoce do câncer; cytology; diagnostic screening programs; early detection of cancer; uterine cervical neoplasms; human papillomavirus; Papiloma vírus humano; Programas de rastreamento; Neoplasias do colo de útero
• ISSN: 0100-7203; 1806-9339; 1806-9339
• DOI: 10.1055/s-0043-1770134

To evaluate the accuracy and patient acceptability toward self-sampling using a new device - SelfCervix® - for detecting HPV-DNA.
 A total of 73 women aged 25-65 who underwent regular cervical cancer screening from March to October 2016 were included. Women performed self-sampling followed by a physician-sampling, and the samples were analyzed for HPV-DNA. After that, patients were surveyed about their acceptability of self-sampling.
 HPV-DNA detection rate of self-sampling presented high accuracy and was similar to physician-collection. Sixty-four (87.7%) patients answered the acceptability survey. Most patients (89%) considered the self-sampling comfortable, and 82.5% preferred self-sampling to physician-sampling. The reasons cited were time-saving and convenience. Fifty-one (79.7%) reported that they would recommend self-sampling.
 Self-sampling using the new Brazilian device SelfCervix® is not inferior in HPV-DNA detection rate compared with physician-collection, and patients are supportive of the method. Therefore, it might be an option to reach under-screened populations in Brazil.